China Dermatology Cro Market Size & Outlook, 2025-2033
Related Markets
China dermatology cro market highlights
- The China dermatology cro market generated a revenue of USD 598.8 million in 2024 and is expected to reach USD 1,148.3 million by 2033.
- The China market is expected to grow at a CAGR of 7.4% from 2025 to 2033.
- In terms of segment, clinical was the largest revenue generating cro type in 2024.
- Preclinical is the most lucrative cro type segment registering the fastest growth during the forecast period.
Dermatology cro market data book summary
| Market revenue in 2024 | USD 598.8 million |
| Market revenue in 2033 | USD 1,148.3 million |
| Growth rate | 7.4% (CAGR from 2025 to 2033) |
| Largest segment | Clinical |
| Fastest growing segment | Preclinical |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Preclinical, Drug Discovery, Clinical |
| Key market players worldwide | IQVIA Holdings Inc, Labcorp Drug Development, Pharmaceutical Product Development, PAREXEL, Charles River Laboratories International Inc, Icon PLC, Medidata, Syneos Health, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, Wuxi AppTec Co Ltd, Medpace Holdings Inc, CTI Clinical Trial and Consulting Services, Eurofins Scientific SE |
Other key industry trends
- In terms of revenue, China accounted for 11.0% of the global dermatology cro market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China dermatology cro market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 721.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dermatology CRO Market Scope
Dermatology CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| CTI Clinical Trial and Consulting Services | View profile | 501-1000 | Covington, Kentucky, United States, North America | http://ctifacts.com |
| Medidata | View profile | 1001-5000 | New York, New York, United States, North America | https://www.medidata.com |
| Pharmaceutical Product Development | View profile | 10001+ | Wilmington, North Carolina, United States, North America | https://ppd.com |
| Pharmaron Beijing Co Ltd Ordinary Shares - Class H | View profile | 20295 | No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Wanchai, Hong Kong, Hong Kong | https://www.pharmaron.com |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.syneoshealth.com/ |
| PAREXEL | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.parexel.com |
| IQVIA Holdings Inc | View profile | 87000 | 2400 Ellis Road, Durham, NC, United States, 27703 | https://www.iqvia.com |
| Labcorp Drug Development | View profile | 10001+ | Princeton, New Jersey, United States, North America | https://drugdevelopment.labcorp.com |
| Medpace Holdings Inc | View profile | 5800 | 5375 Medpace Way, Cincinnati, OH, United States, 45227 | https://www.medpace.com |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
China dermatology cro market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dermatology cro market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 82.21% in 2024. Horizon Databook has segmented the China dermatology cro market based on preclinical, drug discovery, clinical covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to China dermatology cro market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China dermatology cro market databook
-
Our clientele includes a mix of dermatology cro market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China dermatology cro market, including forecasts for subscribers. This country databook contains high-level insights into China dermatology cro market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
China CRO Type - Dermatology Cro Market, 2024 - 2033 (US$M)
China Dermatology CRO Market Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
